Zoonotic

Influenza A/Astrakhan/3212/2020 (H5N8)-like strain (Cber-Rg8a) (Clade 2.3.4.4b) vaccine provides seasonal protection against avian influenza A viruses. This inactivated vaccine targets clade 2.3.4.4b H5N8 strains for intramuscular administration. Designed for adults and children to reduce infection risk during outbreaks. Suitable for travel or occupational exposure scenarios.

This vaccine is used to prevent seasonal influenza caused by the H5N8 strain of avian influenza A. It helps protect individuals at higher risk of exposure, such as poultry workers or travelers to affected regions. The vaccine targets clade 2.3.4.4b, a specific subgroup of H5N8 viruses. It is not a replacement for standard seasonal flu vaccines.

After vaccination, the immune system develops antibodies against the H5N8 strain over several weeks. Common effects include mild soreness at the injection site or low-grade fever. Some individuals may experience fatigue or muscle aches temporarily. These effects typically resolve within a few days.

Store the vaccine refrigerated between 2°C and 8°C and protect from light. Do not freeze. Discard if the vaccine has been frozen or exposed to extreme temperatures. Ensure the recipient has no severe allergies to vaccine components. Consult a healthcare provider if fever or illness is present before vaccination.

No known interactions with other vaccines or medications have been established. However, immunosuppressive therapies may reduce vaccine effectiveness. Avoid receiving other vaccines in the same arm simultaneously unless medically advised. Always inform your healthcare provider about current medications or conditions.